Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$12.21 USD

12.21
6,647,088

+0.71 (6.17%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $12.22 +0.01 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (233 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Company News for Apr 1, 2024

by Zacks Equity Research

Companies In The News Are: RH, AMC, CC, WBA.

Zacks Equity Research

Chemours (CC) Q4 Earnings Beat, Revenue Miss Estimates

by Zacks Equity Research

Chemours (CC) fourth-quarter earnings beat estimates, while sales miss despite growth across TT and TSS segments.

Zacks Equity Research

Chemours (CC) Q4 Earnings Top Estimates

by Zacks Equity Research

Chemours (CC) delivered earnings and revenue surprises of 6.90% and 0.69%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is Chemours (CC) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Should Value Investors Buy Chemours (CC) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Eastman Chemical (EMN) Gains on Cost Cuts and Innovation

by Zacks Equity Research

Eastman Chemical (EMN) benefits from cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.

Zacks Equity Research

LyondellBasell's (LYB) Petrothene T3XL7420 to Optimize Production

by Zacks Equity Research

Petrothene T3XL7420 by LyondellBasell (LYB) passes extensive testing and certification procedures to ensure its quality and dependability.

Zacks Equity Research

Chemours (CC), DuPont & Corteva Back U.S. Water System Deal

by Zacks Equity Research

Chemours (CC), DuPont & Corteva do not intend to exercise the opt-out option and extend support to PFAS Deal with the U.S. Water System.

Zacks Equity Research

Air Products and Chemicals (APD) Up 0.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Air Products and Chemicals (APD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Chemours (CC) Sets Up International F-gas Lifecycle Program

by Zacks Equity Research

This program by Chemours (CC) will incorporate worldwide monitoring to stimulate further adoption, partnerships and reclamation.

Zacks Equity Research

Chemours (CC) Boosts Low GWP HFC-152a Production by 20%

by Zacks Equity Research

Chemours (CC) is increasing HFC-152a production by 20% at its Texas facility to meet the growing demand for eco-friendly propellants and foam-blowing agents.

Zacks Equity Research

Chemours (CC) Q3 Earning Miss, Titanium Technologies Hurt Sales

by Zacks Equity Research

Chemours (CC) lags estimates in Q3 amid lower volumes and soft demand.

Zacks Equity Research

These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks Equity Research

Compared to Estimates, Chemours (CC) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Chemours (CC) Lags Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Chemours (CC) delivered earnings and revenue surprises of -16.88% and 3.63%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

The Zacks Analyst Blog Highlights LyondellBasell, Chemours, Axalta Coating Systems and Ashland

by Zacks Equity Research

LyondellBasell, Chemours, Axalta Coating Systems and Ashland are included in this Analyst Blog.

Anindya Barman headshot

4 Chemical Stocks Set to Pull Off a Beat This Earnings Season

by Anindya Barman

While softer demand in certain end markets is likely to be a drag, LyondellBasell (LYB), Chemours (CC), Axalta Coating Systems (AXTA) and Ashland (ASH) are likely to have benefited from cost and pricing actions.

Zacks Equity Research

Why Chemours (CC) Could Beat Earnings Estimates Again

by Zacks Equity Research

Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Earnings Preview: FMC (FMC) Q3 Earnings Expected to Decline

by Zacks Equity Research

FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

How to Find Strong Basic Materials Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks Equity Research

Are Options Traders Betting on a Big Move in Chemours (CC) Stock?

by Zacks Equity Research

Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.

Zacks Equity Research

Here's Why You Should Hold Onto Chemours (CC) Stock For Now

by Zacks Equity Research

Chemours (CC) gains on strong execution, continued Opteon adoption and its efforts to reduce costs amid headwinds from demand weakness.

Zacks Equity Research

Chemours (CC) Benefits From Opteon Adoption Amid Demand Woes

by Zacks Equity Research

Although Chemours (CC) is being challenged by softer demand in certain businesses, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.

Zacks Equity Research

Here's Why You Should Retain Chemours (CC) in Your Portfolio

by Zacks Equity Research

While Chemours (CC) is exposed to headwinds from demand softness in certain areas, it gains on continued Opteon adoption, strong execution and its cost-reduction and pricing actions.